NCT00718380 2017-11-21
A Phase 1 Study of ABT-869 in Subjects With Solid Tumors
AbbVie
Phase 1 Completed
Clinical Trials
9 trialsNCT00733187 2017-11-21
Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869
AbbVie
Phase 1 Completed
NCT01413893 2017-11-21
An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid Tumors
AbbVie
Phase 1 Completed
NCT01286974 2012-09-21
A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors.
Abbott
Phase 1 Terminated
NCT01506934 2012-08-28
A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors
Abbott
Phase 1 Terminated
NCT01381341 2012-03-23
To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.
Abbott
Phase 1 Completed
NCT01401933 2011-11-02
Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors
Abbott
Phase 1 Completed
NCT01114191 2011-07-26
A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifanib (ABT-869)
Abbott
Phase 1 Completed
NCT00754104 2011-01-19
Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors
Abbott
Phase 1 Withdrawn